Krognes Steve E.
SEC Form 4 insider trading activity
Krognes Steve E. has filed 15 SEC Form 4 filings (18 transaction rows) across 2 companies, including GH, DNLI, with disclosures dating back to 2025. 13 of those filings fall inside the rolling window. Most recent filing: Sep 17, 2026.
On the most recent filing, Krognes Steve E. is listed as Director at Guardant Health, Inc. Inside the rolling window, Krognes Steve E. reported no open-market purchases and 2 open-market sales totaling $2.4M in GH. The largest disclosed transaction in the window is a sale of 9,294 GH shares on Jun 4, 2026, worth $1.2M.
Companies traded
Other insiders at GH
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.4M
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Krognes Steve E. made?
Krognes Steve E. has filed 15 SEC Form 4 filings (18 transaction rows) across 2 companies, including GH, DNLI since 2025.
Which companies does Krognes Steve E. trade?
Krognes Steve E. has filed SEC Form 4 disclosures for 2 companies, including GH, DNLI.
When was Krognes Steve E.'s most recent SEC Form 4 filing?
Krognes Steve E.'s most recent SEC Form 4 filing on Tracefour is dated Sep 17, 2026.
What is Krognes Steve E.'s total buy and sell value in the current window?
Inside the rolling retention window, Krognes Steve E. bought $0 and sold $2.4M based on SEC Form 4 filings.
What was Krognes Steve E.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 9,294 GH shares on 2026-06-04, worth $1.2M, per SEC Form 4 filings.